Health and Wellness Strategy Consulting

EY-Parthenon Health and Wellness Strategy Consulting teams help develop and deliver growth, transaction, digital and value creation strategies. We help health and life sciences organizations build greater financial and operational resilience and technical agility, supporting their future growth within an ever-changing landscape.

What the EY-Parthenon Health and Wellness Strategy Consulting teams can do for you

As the Health Sciences and Wellness industry is transforming, EY-Parthenon Health Strategy Consulting teams can help you answer some of your most critical questions:

How should I refine my business strategy to meet evolving customer needs and the ever-changing health and wellness landscape?
How can I reinvent my operating model and go-to-market strategy?
How can I hone my organization’s strategy to strengthen its operational resilience?
How can I grow market share through investment in digital innovation? How can I leverage the ecosystem to scale my products and services?
What type of transaction or partnership will propel our organization’s growth and pair with consumer needs?
What is the right strategy, to buy, build or partner, and to solve the innovation deficit?

EY-Parthenon Health and Wellness strategy professionals can advise clients on developing growth strategies by providing broad market, competitor and customer insights. But a strategy alone is not enough: we also help organizations execute strategy through real operational change. We help them transform the vision into reality by leveraging strategic, financial and operational perspectives, based on deep sector experience and firmwide knowledge to help enable end-to-end execution.

EY-Parthenon Transaction Strategy teams help clients realize their full potential through fast-tracked, better-informed decisions across the entire deal lifecycle. We guide clients from M&A or divestment strategy, planning, transaction diligence and specialized health due diligence processes, through the integration or separation phases of a transaction — to build long-term value.

EY-Parthenon Turnaround Strategy teams can work with stakeholders to rapidly provide broad strategic, financial, operational, tax, turnaround and restructuring advice to help address business issues in critical and complex situations. From value creation to restructuring, we can help when health and life sciences organizations face financial or operational challenges.

Today’s patients are consumers who expect more from their health and wellness experiences: seamless and simplified processes, faster engagement, virtual and on-site care that is convenient, responsive and effective. Health care organizations are employing data in myriad ways, trying to unlock value and understand all components that contribute to people’s complex health journeys. Data can inform health care providers and payers to understand these drivers and anticipate health care needs. It can also be leveraged to analyze an organization’s internal operations and markets more deeply, to make better informed, strategic choices that bolster financial sustainability.

The massive amount of data, quickly evolving technologies and the many ecosystems in health care can be overwhelming and complex. By focusing on what matters most to health organizations’ consumers and workforce, EY-Parthenon teams can bring together these three critical aspects to help create a technology-enabled, personalized health and wellness experience, supporting health care organizations to advance their missions to serve and improve the health and wellbeing of their populations.

EY-Parthenon Health and Wellness Strategy Consulting teams can help organizations shore up their operations today, while positioning themselves for future success. We understand and work with the broad health ecosystem every day. We understand what consumers demand and what capabilities are needed to meet and exceed their demands. We are here to help organizations succeed in their quest to provide health care that is predictive, personalized and equitable.
The Life Sciences industry has excited the world by leveraging new platforms to address some of society’s most pressing health problems. But the industry is also facing an innovation deficit that requires an ecosystem mindset to find new avenues for growth in particular, as specialty drug spending far outpaces traditional drug spending. New modalities that have emerged include gene and cell therapies, mRNA drugs or vaccines, and complex biologics.

At the same time, costs of capital are increasing, leading an industry that has focused on topline growth to address costs, and strengthen financial and operational resilience. All of this, as digital disrupts operating models and how care is delivered, while regulatory considerations transform pharmaceutical supply chains.

EY-Parthenon Health and Wellness Strategy Consulting teams cover a broad spectrum of life science services for both corporate and private equity clients, including biopharma (branded and generics), medical technology, life science services (CRO and CDMO), diagnostics, life science tools and reagents. Through corporate and growth strategy services, we provide in-depth, real-world perspectives and identify inorganic growth options that lead to M&A programs. Through commercial due diligence services, we help create heavily researched, data-backed insights for our clients. We also help you develop and implement innovation strategies around digital capabilities and emerging technologies.

Through Health and Wellness Strategy Consulting, EY-Parthenon teams help leaders design and deliver transformative strategies to build long-term value.

EY-Parthenon Health and Wellness Strategy Consulting teams

Our latest thinking

How global events are shaping the pharmaceutical supply chain

In this episode, EY leaders discuss critical supply chain issues pertaining to life sciences companies. Listen to the podcast.

23m 55s

How life sciences can make the right deals in a time of change

Life sciences companies are returning to dealmaking amid cost and revenue pressures – how will they find the right deals to secure value? Learn more.

Subin Baral

How ecosystem participation drives more value for life sciences deals

Biopharmas need to embrace strategic partnerships that share risk and reward to achieve their growth ambitions. Learn more.

Subin Baral

How to give health consumers the access and experience they value most

The EY Global Consumer Health Survey 2023 findings suggest health executives should focus on access to care, cost and experience factors. Learn more.

Virtual and in-person care merge for a healthier future

Health systems should seize on recent progress to push toward new models that seamlessly integrate virtual, home-based and in-person care. Learn more.

Commercial Strategy Consulting

Our Commercial Consulting Services teams help you realize enterprise growth, improve profitability, and extend customer and shareholder value. Learn more.
Read more
Advanced analytics

Discover how EY tech-enabled Strategy and Transactions advanced analytics teams helps turn information into connected intelligent insights.
Read more
AI Strategy Consulting and M&A

AI strategy consulting teams can enable better and faster ROI for new products and services and help accelerate M&A. Find out more.
Read more

EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients. For more information about our organization, please visit ey.com.

EY-Parthenon is a brand under which a number of EY member firms across the globe provide strategy consulting services.

Health and Wellness Strategy Consulting

What the EY-Parthenon Health and Wellness Strategy Consulting teams can do for you

Health care

Life Sciences

EY-Parthenon Health and Wellness Strategy Consulting teams

Ranu Carroll

H. Mallory Caldwell

Abhay Bangi

Olaf Zweig

Arda Ural, PhD